Background: Anthracycline therapy for acute leukemia may be associated with significant morbidity and mortality in children or elderly patients that have a degree of heart failure. Patients with prior anthracycline exposure. those with pre-existing heart disease. or who have received the total anthracycline dose present an increased risk for cardiotoxicity. https://lockdownsecuritycanada.shop/product-category/spdif-adapter/